News Blog

News Blog


Spinal cord stem-cell trial could start soon, report says

A clinical trial that would test the use of embryonic stem cells to treat spinal cord injury could begin within three months.

The Scientist is reporting that the Food and Drug Administration (FDA) may lift its hold on a trial sponsored by California biotech Geron Corp. by early next year. In May, the agency ordered Geron to delay the trial while it studied how best to regulate stem-cell-based therapies.

The phase 1 trial would test whether it is safe to inject nerve cells into the site of a spinal cord injury. A study published in 2005 in the Journal of Neuroscience found that giving rats the injections seven days after a spinal cord injury improved their motor function.

Geron president and CEO Tom Okarma said there's no indication that politics were behind the FDA's delayed approval, according to The Scientist. He made his remarks at the New York Stem Cell Foundation conference at Rockefeller University last Wednesday.

President Bush banned federally funded research on embryonic stem cell lines created after Aug. 9, 2001. Democratic Presidential nominee Barack Obama told the group Science Debate 2008 that he would lift the limit, but John McCain, who has said he supports such research, has not made clear whether he would do so.

Among the concerns about stem cell therapy is whether it might cause cancer.

An FDA spokeswoman said the agency doesn't comment on products under development.

(Updated at 8:10 a.m. Tuesday with FDA response.)

(Image by iStockphoto/Mads Abildgaard)

 

 

Tags: Stem Cells, FDA, neurons, spinal cord
More News Blog: Next: Study clears acrylamide of gastrointestinal cancer link Previous: Could a mild flu pandemic prevent a more deadly one?

4 Comments

Add Comment
View
  1. 1. freddyboy 08:29 PM 10/23/08

    This article doesn't seem to offer any strong evidence in support of a lift of the hold. Only that a new administration will increase funding. However the CEO of Geron has said that the hold wasn't political. We knew all this already! where is the news? Has the FDA finally written a letter explaining the hold? not as far as I can tell - at least Geron hasn't released it yet. It is very frustrating to finally find a new article relating to this ridiculous hold and then find that its one interesting claim (where did this "3 months" figure come from?) is void of complimentary evidence.

    Reply | Report Abuse | Link to this
  2. 2. Mirella Cueva 08:48 PM 1/6/09

    Casey Nabavi and Cellulogix Biosciences recently opened their headquarters in Montreal, Canada. With treatment centers in Zona Rio, Mexico and Istanbul, Turkey. Coming soon are treatment centers in Germany and Russia, as well as Cabo San Lucas.

    www.cellulogixintl.com

    Reply | Report Abuse | Link to this
  3. 3. Outdischair 11:15 PM 5/21/09

    Plz plz give me a call or email me about your injection been in a wheelchair to long got feeling but can move my legs will do whatever it take anyone somebody plz contact me at wallace601@bellsouth.net GoD is watching and he sent me here so plz contact.

    Reply | Report Abuse | Link to this
  4. 4. kaushikshahukar 06:17 AM 6/3/10

    Does Stem Cell is useful in Curing Secondary Dystonia how superior is to brain stinulation Surgery.

    Regards

    kaushik Shahukar
    (9892942721)

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

More »

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital
  SA Digital

Email this Article

Spinal cord stem-cell trial could start soon, report says: Scientific American Blog

X
Scientific American Magazine

Subscribe Today

Save 66% off the cover price and get a free gift!

Learn More >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X

About the Bering in Mind Blog

In this column presented by Scientific American Mind magazine, research psychologist Jesse Bering of Queen's University Belfast ponders some of the more obscure aspects of everyday human behavior. Ever wonder why yawning is contagious, why we point with our index fingers instead of our thumbs or whether being breastfed as an infant influences your sexual preferences as an adult? Get a closer look at the latest data as "Bering in Mind" tackles these and other quirky questions about human nature. Sign up for the RSS feed or friend Dr. Bering on Facebook and never miss an installment again.

X

About the Cross-check Blog

Every week, John Horgan takes a puckish, provocative look at breaking science. A former staff writer at Scientific American, he is the author of several books—most notably, The End of Science: Facing the Limits of Knowledge in the Twilight of the Scientific Age. He currently directs the Center for Science Writings at Stevens Institute of Technology. He lives in New York State's Hudson Highlands, where he plays ice hockey each winter to hone his cross-checking skills.

X

Expeditions Blog

Ever wonder what it's really like to be working in Antarctica or collecting core samples from the middle of the Pacific Ocean? Get a first-hand feel for scientific exploration by following the blog posts of researchers out in the field.

X

About the Extinction Countdown Blog

Several times a week, John Platt shines a light on endangered species from all over the globe, exploring not just why they are dying out but also what's being done to rescue them from oblivion. From unusual or little-known organisms like the giant spitting earthworm and the stinking hawk's-beard to popular favorites like cheetahs and koalas, Platt, a journalist specializing in environmental issues and technology, does his part to slow the countdown.

X

About the Guest Blog

The editors of Scientific American regularly encounter perspectives on science and technology that we believe our readers would find thought-provoking, fascinating, debatable and challenging. The guest blog is a forum for such opinions. The views expressed belong to the author and are not necessarily shared by Scientific American.

X

About the Solar at Home Blog

Follow Scientific American editor George Musser as he installs--or tries to install--solar photovoltaic panels on the roof of his suburban New Jersey home. You'll learn the literal nuts and bolts of going green with the sun and get energy-saving tips even if you aren't putting up panels.

Write to us with tips or comments at blog@sciam.com and follow us on Twitter: http://twitter.com/sciam.

X